US Stock MarketDetailed Quotes

Atossa Therapeutics (ATOS)

Watchlist
  • 5.160
  • -0.340-6.18%
Close May 12 16:00 ET
  • 5.280
  • +0.120+2.33%
Post 19:30 ET
44.43MMarket Cap-1.18P/E (TTM)

Atossa Therapeutics (ATOS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-60.78%-9.58M
-41.52%-29.76M
-49.47%-10.54M
-26.42%-6.01M
-60.21%-7.26M
-26.84%-5.96M
-0.43%-21.03M
-26.57%-7.05M
-22.33%-4.75M
-1.48%-4.53M
Net income from continuing operations
-42.74%-9.59M
-36.33%-34.77M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
Operating gains losses
----
----
----
----
----
----
--7K
--4K
---1K
--2K
Depreciation and amortization
0.00%4K
-5.88%16K
0.00%4K
0.00%4K
0.00%4K
-20.00%4K
-26.09%17K
-71.43%4K
33.33%4K
33.33%4K
Change In working capital
-473.96%-718K
423.66%2.35M
92.66%-109K
10,450.00%1.9M
-68.62%364K
-74.60%192K
-70.51%448K
-190.06%-1.49M
-98.73%18K
50.85%1.16M
-Change in prepaid assets
-147.45%-631K
-345.08%-946K
52.72%-486K
640.52%827K
-214.29%-1.03M
-138.40%-255K
-89.12%386K
-623.94%-1.03M
-105.11%-153K
132.73%903K
-Change in payables and accrued expense
-116.53%-224K
2,311.05%4M
104.77%79K
348.97%1.31M
947.50%1.26M
27.35%1.36M
91.94%-181K
-728.50%-1.66M
89.61%292K
151.72%120K
-Change in other current assets
6,563.64%711K
-98.79%4K
-7.55%343K
-563.38%-329K
100.90%1K
---11K
119.51%331K
--371K
104.18%71K
-11,000.00%-111K
-Change in other current liabilities
78.26%41K
-38.51%-410K
-1,870.37%-478K
106.05%19K
181.25%26K
0.00%23K
-116.59%-296K
-98.48%27K
-1,156.00%-314K
-68.42%-32K
-Change in other working capital
33.15%-615K
-246.15%-304K
-45.94%433K
-41.80%71K
-60.00%112K
7.54%-920K
61.24%208K
281.43%801K
1,209.09%122K
-55.77%280K
Cash from discontinued investing activities
Operating cash flow
-60.78%-9.58M
-41.52%-29.76M
-49.47%-10.54M
-26.42%-6.01M
-60.21%-7.26M
-26.84%-5.96M
-0.43%-21.03M
-26.57%-7.05M
-22.33%-4.75M
-1.48%-4.53M
Investing cash flow
Cash flow from continuing investing activities
0
-21.05%-23K
-7K
30.00%-7K
0
-50.00%-9K
-35.71%-19K
0
-900.00%-10K
76.92%-3K
Net PPE purchase and sale
--0
-21.05%-23K
---7K
30.00%-7K
--0
-50.00%-9K
-35.71%-19K
--0
-900.00%-10K
76.92%-3K
Cash from discontinued investing activities
Investing cash flow
--0
-21.05%-23K
---7K
30.00%-7K
--0
-50.00%-9K
-35.71%-19K
--0
-900.00%-10K
76.92%-3K
Financing cash flow
Cash flow from continuing financing activities
0
0
0
0
0
349.02%3.67M
3.37M
0
100K
Net common stock issuance
----
----
----
----
----
----
--0
--0
----
----
Proceeds from stock option exercised by employees
----
--0
--0
--0
--0
--0
--3.67M
--3.37M
--0
--100K
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
--0
--0
--0
349.02%3.67M
--3.37M
--0
--100K
Net cash flow
Beginning cash position
-41.84%41.41M
-19.62%71.19M
-30.61%51.96M
-27.21%57.97M
-22.41%65.23M
-19.62%71.19M
-20.21%88.57M
-20.46%74.88M
-19.96%79.64M
-19.15%84.07M
Current changes in cash
-60.54%-9.58M
-71.41%-29.79M
-186.42%-10.55M
-26.30%-6.01M
-63.71%-7.26M
-32.62%-5.97M
22.53%-17.38M
33.91%-3.68M
11.18%-4.76M
0.98%-4.43M
End cash Position
-51.20%31.83M
-41.84%41.41M
-41.84%41.41M
-30.61%51.96M
-27.21%57.97M
-22.41%65.23M
-19.62%71.19M
-19.62%71.19M
-20.46%74.88M
-19.96%79.64M
Free cash flow
-60.54%-9.58M
-41.50%-29.79M
-49.57%-10.55M
-26.30%-6.01M
-60.10%-7.26M
-26.87%-5.97M
-0.45%-21.05M
-26.57%-7.05M
-22.55%-4.76M
-1.25%-4.53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -60.78%-9.58M-41.52%-29.76M-49.47%-10.54M-26.42%-6.01M-60.21%-7.26M-26.84%-5.96M-0.43%-21.03M-26.57%-7.05M-22.33%-4.75M-1.48%-4.53M
Net income from continuing operations -42.74%-9.59M-36.33%-34.77M-72.32%-10.94M-20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M
Operating gains losses --------------------------7K--4K---1K--2K
Depreciation and amortization 0.00%4K-5.88%16K0.00%4K0.00%4K0.00%4K-20.00%4K-26.09%17K-71.43%4K33.33%4K33.33%4K
Change In working capital -473.96%-718K423.66%2.35M92.66%-109K10,450.00%1.9M-68.62%364K-74.60%192K-70.51%448K-190.06%-1.49M-98.73%18K50.85%1.16M
-Change in prepaid assets -147.45%-631K-345.08%-946K52.72%-486K640.52%827K-214.29%-1.03M-138.40%-255K-89.12%386K-623.94%-1.03M-105.11%-153K132.73%903K
-Change in payables and accrued expense -116.53%-224K2,311.05%4M104.77%79K348.97%1.31M947.50%1.26M27.35%1.36M91.94%-181K-728.50%-1.66M89.61%292K151.72%120K
-Change in other current assets 6,563.64%711K-98.79%4K-7.55%343K-563.38%-329K100.90%1K---11K119.51%331K--371K104.18%71K-11,000.00%-111K
-Change in other current liabilities 78.26%41K-38.51%-410K-1,870.37%-478K106.05%19K181.25%26K0.00%23K-116.59%-296K-98.48%27K-1,156.00%-314K-68.42%-32K
-Change in other working capital 33.15%-615K-246.15%-304K-45.94%433K-41.80%71K-60.00%112K7.54%-920K61.24%208K281.43%801K1,209.09%122K-55.77%280K
Cash from discontinued investing activities
Operating cash flow -60.78%-9.58M-41.52%-29.76M-49.47%-10.54M-26.42%-6.01M-60.21%-7.26M-26.84%-5.96M-0.43%-21.03M-26.57%-7.05M-22.33%-4.75M-1.48%-4.53M
Investing cash flow
Cash flow from continuing investing activities 0-21.05%-23K-7K30.00%-7K0-50.00%-9K-35.71%-19K0-900.00%-10K76.92%-3K
Net PPE purchase and sale --0-21.05%-23K---7K30.00%-7K--0-50.00%-9K-35.71%-19K--0-900.00%-10K76.92%-3K
Cash from discontinued investing activities
Investing cash flow --0-21.05%-23K---7K30.00%-7K--0-50.00%-9K-35.71%-19K--0-900.00%-10K76.92%-3K
Financing cash flow
Cash flow from continuing financing activities 00000349.02%3.67M3.37M0100K
Net common stock issuance --------------------------0--0--------
Proceeds from stock option exercised by employees ------0--0--0--0--0--3.67M--3.37M--0--100K
Cash from discontinued financing activities
Financing cash flow --0--0--0--0--0--0349.02%3.67M--3.37M--0--100K
Net cash flow
Beginning cash position -41.84%41.41M-19.62%71.19M-30.61%51.96M-27.21%57.97M-22.41%65.23M-19.62%71.19M-20.21%88.57M-20.46%74.88M-19.96%79.64M-19.15%84.07M
Current changes in cash -60.54%-9.58M-71.41%-29.79M-186.42%-10.55M-26.30%-6.01M-63.71%-7.26M-32.62%-5.97M22.53%-17.38M33.91%-3.68M11.18%-4.76M0.98%-4.43M
End cash Position -51.20%31.83M-41.84%41.41M-41.84%41.41M-30.61%51.96M-27.21%57.97M-22.41%65.23M-19.62%71.19M-19.62%71.19M-20.46%74.88M-19.96%79.64M
Free cash flow -60.54%-9.58M-41.50%-29.79M-49.57%-10.55M-26.30%-6.01M-60.10%-7.26M-26.87%-5.97M-0.45%-21.05M-26.57%-7.05M-22.55%-4.76M-1.25%-4.53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More